NDAINJECTIONINJECTABLE
Approved
Dec 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium Chromate Cr-51 is a radioactive diagnostic agent used for nuclear medicine imaging to assess red blood cell survival and detect gastrointestinal bleeding. It is not a traditional pharmaceutical with a mechanism of action, but rather a radiopharmaceutical tracer that localizes to red blood cells for diagnostic visualization.
LOE Approaching
This is a mature diagnostic radiopharmaceutical with limited team expansion potential as it approaches loss of exclusivity and faces declining utilization in nuclear medicine.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Sodium Chromate Cr-51 offers limited career growth due to minimal linked job opportunities and a declining market driven by diagnostic modality shifts. This role is best suited for professionals seeking stability in a niche specialty pharmaceutical function or manufacturing operations rather than commercial expansion.
Radiopharmaceutical SpecialistNuclear Medicine Support Scientist
Worked on SODIUM CHROMATE CR 51 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.